<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bağırsak mikrobiyotası &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/bagirsak-mikrobiyotasi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 10:10:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Bağırsak mikrobiyotası &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Mucosal Glycans: Key Players in Inflammatory Bowel Disease</title>
		<link>https://bioengineer.org/mucosal-glycans-key-players-in-inflammatory-bowel-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 10:09:49 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[bağırs]]></category>
		<category><![CDATA[Bağırsak mikrobiyotası]]></category>
		<category><![CDATA[glikokaliks]]></category>
		<category><![CDATA[immün modülasyon** **Açıklama:** 1. **mukoza glikanları:** Yazının ana konusu]]></category>
		<category><![CDATA[İnflamatuar bağırsak hastalığı]]></category>
		<category><![CDATA[İşte bu içerik için uygun 5 Türkçe etiket (virgülle ayrılmış): **mukoza glikanları]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mucosal-glycans-key-players-in-inflammatory-bowel-disease/</guid>

					<description><![CDATA[In the intricate world of immunology and gut health, glycans – a class of carbohydrates – emerge as vital players orchestrating a symphony of immune responses. These biomolecules are not merely structural components; they serve as critical modulators of both physiological and pathological processes in the human body. Their significance is particularly pronounced in inflammatory [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318251</post-id>	</item>
		<item>
		<title>How Gut Microbiota Influences Pancreatic Cancer Immunotherapy</title>
		<link>https://bioengineer.org/how-gut-microbiota-influences-pancreatic-cancer-immunotherapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 09:45:35 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Bağırsak mikrobiyotası]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: **Gut Microbiota]]></category>
		<category><![CDATA[İmmün mikroçevre]]></category>
		<category><![CDATA[immune microenvironment]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[Kanser immünoterapisi]]></category>
		<category><![CDATA[Microbiome Modulation** **Açıklama:** 1. **Gut Microbiota:** Makalenin temel konusu ve etkisi araştırılan unsur. 2. **Pancreatic Cancer:** Çalışmanın odaklandığı spesifik kanser türü. 3]]></category>
		<category><![CDATA[Mikrobiyom Modülasyonu]]></category>
		<category><![CDATA[pancreatic cancer]]></category>
		<category><![CDATA[Pankreas Kanseri İmmünoterapisi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/how-gut-microbiota-influences-pancreatic-cancer-immunotherapy/</guid>

					<description><![CDATA[A groundbreaking study has recently emerged, spotlighting the significant role that gut microbiota play in reshaping the immune microenvironment within pancreatic cancer. This research provides compelling evidence suggesting that the unique composition of gut bacteria could create new pathways for immunotherapy in this notoriously challenging type of cancer. The potential implications of this discovery extend [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318234</post-id>	</item>
		<item>
		<title>Liver and Gut: Key Players in Cholesterol Balance</title>
		<link>https://bioengineer.org/liver-and-gut-key-players-in-cholesterol-balance/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 00:08:33 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Bağırsak mikrobiyotası]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket: **kolesterol metabolizması]]></category>
		<category><![CDATA[karaciğer-bağırsak ekseni]]></category>
		<category><![CDATA[kolesterolün sentezi]]></category>
		<category><![CDATA[nükleer reseptörler** **Açıklama:** 1. **Kolesterol metabolizması:** Makalenin temel konusu]]></category>
		<category><![CDATA[safra asidi sentezi]]></category>
		<category><![CDATA[taşın]]></category>
		<guid isPermaLink="false">https://bioengineer.org/liver-and-gut-key-players-in-cholesterol-balance/</guid>

					<description><![CDATA[Cholesterol has long been considered a primary actor in cardiovascular health, but recent findings reveal its intricate connection to a host of diseases beyond the heart and blood vessels. The gut and liver, two pivotal organs in whole-body cholesterol metabolism, are front and center in this emerging narrative. The production and secretion of plasma lipoproteins, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318083</post-id>	</item>
		<item>
		<title>Citalopram Affects Gut Microbes in Female Rats Only</title>
		<link>https://bioengineer.org/citalopram-affects-gut-microbes-in-female-rats-only/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 11 Dec 2025 17:00:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bağırsak mikrobiyotası]]></category>
		<category><![CDATA[Dişi Yavrular]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket: **Cinsiyete Bağlı Etkiler]]></category>
		<category><![CDATA[Metabolik Profil Değişiklikleri** **Açıklama:** 1. **Cinsiyete Bağlı Etkiler:** Çalışmanın en çarpıc]]></category>
		<category><![CDATA[Perinatal SSRI Maruziyeti]]></category>
		<guid isPermaLink="false">https://bioengineer.org/citalopram-affects-gut-microbes-in-female-rats-only/</guid>

					<description><![CDATA[Citalopram’s Impact on Gut Microbiota in Perinatal Exposure: Insights from a Groundbreaking Study Recent research has delved deep into the intricate relationship between maternal psychotropic medication during pregnancy and the subsequent effects on offspring, particularly focusing on the gut microbiome. The study conducted by Kropp, Glover, and Samanta published in Biological Sex Differences provides compelling [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">306092</post-id>	</item>
		<item>
		<title>Schisantherin A Boosts Fat Burning via Gut Bacteria</title>
		<link>https://bioengineer.org/schisantherin-a-boosts-fat-burning-via-gut-bacteria/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 11 Dec 2025 10:05:23 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bağırsak mikrobiyotası]]></category>
		<category><![CDATA[obezite tedavisi]]></category>
		<category><![CDATA[Schisantherin A]]></category>
		<category><![CDATA[termojenez]]></category>
		<category><![CDATA[TGR5 sinyal yolu **Açıklama:** 1. **Schisantherin A:** Ana çalışma konusu olan bileşik. 2. **Bağırsak mikrobiyotası:** Çalışmanın temel mekanizmasının (Schisantherin A'n]]></category>
		<guid isPermaLink="false">https://bioengineer.org/schisantherin-a-boosts-fat-burning-via-gut-bacteria/</guid>

					<description><![CDATA[In a groundbreaking development that could redefine the future of obesity treatment, researchers have unveiled the remarkable potential of Schisantherin A, a natural compound, to activate fat-burning processes in obese mice through a sophisticated interplay with gut bacteria and cellular signaling pathways. This innovative study not only highlights the profound influence of the gut microbiome [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">305749</post-id>	</item>
		<item>
		<title>Host Proteins Influence Hemorrhagic Shock Through Gut Microbiota</title>
		<link>https://bioengineer.org/host-proteins-influence-hemorrhagic-shock-through-gut-microbiota/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 25 Nov 2025 11:00:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bağırsak mikrobiyotası]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Hemorajik şok]]></category>
		<category><![CDATA[İnflamasyon terapötikleri** * **Hemorajik şok**: İçeriğin temel odağı. * **Konak stres proteinleri**: Anahtar bileşen ve etki mekan]]></category>
		<category><![CDATA[Konak stres proteinleri]]></category>
		<category><![CDATA[Mendelian randomizasyon]]></category>
		<guid isPermaLink="false">https://bioengineer.org/host-proteins-influence-hemorrhagic-shock-through-gut-microbiota/</guid>

					<description><![CDATA[Recent research has elucidated the intricate relationship between host stress proteins and their influence on gut microbiota, particularly in the context of hemorrhagic shock. This groundbreaking study led by Deng, Wu, and Xiong, highlights the foundational role of these proteins in shaping the body’s response to significant blood loss. Through a combination of Mendelian randomization [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">300980</post-id>	</item>
	</channel>
</rss>
